![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DJO Global Wins FDA Marketing Clearance for Exprt Revision Hip
DJO Global Wins FDA Marketing Clearance for Exprt Revision Hip
March 15, 2017
The FDA has granted DJO Global marketing clearance for its Exprt revision hip.
The device is a joint implant that connects the femoral bone to the hip. The "ball" on top of the stem device is composed of three shells or femoral heads ranging from 22-44mm. — Cynthia Jessup
Upcoming Events
-
21Oct